Deregulation of the PI3K pathway plays a critical role in the development and progression of cancer, and has been frequently implicated in a wide spectrum of malignancies, including glioma, prostate, breast, ovarian, and endometrial cancer. This evidence concerns the gene PIK3CG and glioma.